AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 150 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,126,000 | +47.9% | 536,873 | -30.6% | 0.04% | +17.6% |
| Q3 2019 | $21,721,000 | +10.7% | 773,279 | +49.2% | 0.03% | +17.2% |
| Q2 2019 | $19,619,000 | -29.3% | 518,193 | -27.1% | 0.03% | -31.0% |
| Q1 2019 | $27,736,000 | +120.1% | 710,809 | +20.3% | 0.04% | +110.0% |
| Q4 2018 | $12,600,000 | -2.2% | 590,974 | +75.3% | 0.02% | +17.6% |
| Q2 2018 | $12,879,000 | +102.8% | 337,055 | +59.5% | 0.02% | +112.5% |
| Q1 2018 | $6,351,000 | +87.0% | 211,348 | +74.3% | 0.01% | +60.0% |
| Q3 2017 | $3,397,000 | -2.1% | 121,275 | -33.1% | 0.01% | -16.7% |
| Q2 2017 | $3,470,000 | +135.6% | 181,370 | +109.8% | 0.01% | +100.0% |
| Q1 2017 | $1,473,000 | -8.1% | 86,437 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $1,603,000 | – | 87,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |